Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126990211 | 12699021 | 1 | I | 20160825 | 20160830 | 20160830 | PER | US-GLAXOSMITHKLINE-US2016124881 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126990211 | 12699021 | 1 | SS | EXCEDRIN MILD HEADACHE CAPLETS | ACETAMINOPHENCAFFEINE | 1 | Oral | U | 0 | ||||||||||
| 126990211 | 12699021 | 2 | SS | EXCEDRIN MILD HEADACHE CAPLETS | ACETAMINOPHENCAFFEINE | 1 | U | 0 | |||||||||||
| 126990211 | 12699021 | 3 | SS | EXCEDRIN MILD HEADACHE CAPLETS | ACETAMINOPHENCAFFEINE | 1 | U | 0 | |||||||||||
| 126990211 | 12699021 | 4 | SS | EXCEDRIN TENSION HEADACHE | ACETAMINOPHENCAFFEINE | 1 | Oral | U | UNK | 0 | TABLET | ||||||||
| 126990211 | 12699021 | 5 | SS | EXCEDRIN TENSION HEADACHE | ACETAMINOPHENCAFFEINE | 1 | U | 0 | TABLET | ||||||||||
| 126990211 | 12699021 | 6 | SS | EXCEDRIN TENSION HEADACHE | ACETAMINOPHENCAFFEINE | 1 | U | 0 | TABLET | ||||||||||
| 126990211 | 12699021 | 7 | PS | EXCEDRIN MIGRAINE | ACETAMINOPHENASPIRINCAFFEINE | 1 | Oral | U | 20802 | TABLET | |||||||||
| 126990211 | 12699021 | 8 | SS | EXCEDRIN MIGRAINE | ACETAMINOPHENASPIRINCAFFEINE | 1 | U | 20802 | TABLET | ||||||||||
| 126990211 | 12699021 | 9 | SS | EXCEDRIN MIGRAINE | ACETAMINOPHENASPIRINCAFFEINE | 1 | U | 20802 | TABLET | ||||||||||
| 126990211 | 12699021 | 10 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | U | 0 | ||||||||||
| 126990211 | 12699021 | 11 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 126990211 | 12699021 | 12 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126990211 | 12699021 | 1 | Migraine |
| 126990211 | 12699021 | 2 | Migraine with aura |
| 126990211 | 12699021 | 3 | Headache |
| 126990211 | 12699021 | 4 | Migraine |
| 126990211 | 12699021 | 5 | Migraine with aura |
| 126990211 | 12699021 | 6 | Headache |
| 126990211 | 12699021 | 7 | Migraine |
| 126990211 | 12699021 | 8 | Migraine with aura |
| 126990211 | 12699021 | 9 | Headache |
| 126990211 | 12699021 | 10 | Migraine |
| 126990211 | 12699021 | 11 | Migraine with aura |
| 126990211 | 12699021 | 12 | Headache |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126990211 | 12699021 | Drug effect increased | |
| 126990211 | 12699021 | Drug ineffective | |
| 126990211 | 12699021 | Drug ineffective for unapproved indication | |
| 126990211 | 12699021 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |